Vanessa M Mazandi, Shih-Shan Lang, Raphia K Rahman, Akira Nishisaki, Forrest Beaulieu, Bingqing Zhang, Heather Griffis, Alexander M Tucker, Phillip B Storm, Greg G Heuer, Avi A Gajjar, Steve B Ampah, Matthew P Kirschen, Alexis A Topjian, Ian Yuan, Conall Francoeur, Todd J Kilbaugh, Jimmy W Huh
BACKGROUND: Ketamine has traditionally been avoided as an induction agent for tracheal intubation in patients with neurologic conditions at risk for intracranial hypertension due to conflicting data in the literature. The objective of this study was to evaluate and compare the effects of ketamine versus other medications as the primary induction agent on peri-intubation neurologic, hemodynamic and respiratory associated events in pediatric patients with neurologic conditions at risk for intracranial hypertension...
April 2023: Neurocritical Care